▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Clicks Group in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $35.90.
The current consensus among 1 investment analysts is to buy stock in Clicks Group.
Clicks Group Limited operates as a health and beauty retailer, and pharmaceutical distributor and wholesaler primarily in South Africa. The company operates in two segments, Retail and Distribution. It retails pharmacy, health and beauty through approximately 740 stores, and 580 in-store pharmacies for the middle to upper income markets under the Clicks name. The company also retails specialty health and wellness products, including vitamins, mineral and herbal supplements, sports nutrition, and slimming products under the General Nutrition Corporation (GNC) name; luxury toiletries, cosmetics, gifting, and grooming products under The Body Shop name; and fashionable jewelry and accessories for young women and girls under the Claire's name. In addition, it retails music and related entertainment merchandise, such as music and movie DVDs; computer games; and technology and accessories comprising headphones portable speakers, phone and tablet covers, docking stations, and tablets under the Musica name. Further, the company is involved in the wholesale and supply of pharmaceutical products to retail pharmacies, private hospitals, dispensing doctors, and retail health stores under the UPD name. The company was formerly known as New Clicks Holdings Limited and changed its name to Clicks Group Limited in June 2009. Clicks Group Limited was founded in 1968 and is based in Cape Town, South Africa.